Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1407
Small font sizeDefault font sizeIncrease font size
Navigate here
  Search
 
  
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »  Article in PDF (692 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

 
  In this article
 »  References
 »  Article Figures

 Article Access Statistics
    Viewed1993    
    Printed87    
    Emailed0    
    PDF Downloaded208    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
LETTER TO EDITOR
Year : 2011  |  Volume : 48  |  Issue : 1  |  Page : 131-132
 

Nephrotic syndrome in plasma cell leukaemia - A rare presentation


Departamento Medicina Interna Hospital São Marcos, 4700 Braga, Portugal

Date of Web Publication10-Feb-2011

Correspondence Address:
M Diogo
Departamento Medicina Interna Hospital São Marcos, 4700 Braga
Portugal
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.76644

Rights and Permissions



How to cite this article:
Diogo M, Faustino C, Pimentel T, Amorim J, Tavares i. Nephrotic syndrome in plasma cell leukaemia - A rare presentation. Indian J Cancer 2011;48:131-2

How to cite this URL:
Diogo M, Faustino C, Pimentel T, Amorim J, Tavares i. Nephrotic syndrome in plasma cell leukaemia - A rare presentation. Indian J Cancer [serial online] 2011 [cited 2019 Aug 21];48:131-2. Available from: http://www.indianjcancer.com/text.asp?2011/48/1/131/76644


Sir,

Being less than 5% of all plasma cell disorders, most publications on plasma cell leukaemia (PCL) are based on case reports. In 2005 a 57- year- old man was admitted to our institution because of edema and dyspnea. He had a 1- month history of fatigue, anorexia, weight loss of 8 kg and a sharply delimited dorsal pain. Physical examination revealed pallor, hepatomegaly and edema. Laboratory data were as follows: hemoglobin 9.9 g/dl, white blood cell count 10.7× 10 9 /l with 65% plasmacytoid lymphocytes, urea of 580 mg/l and creatinine of 34 mg/l. Calcium was elevated as well as β2 - microglobulin (26144 ng/ml). There was no M- component. A skeletal bone survey showed an osteolytic lesion at the dorsal spine with fracture and small lesions at the lumbar spine. Ultrasonography revealed no renal alterations. Urine protein electrophoresis showed κ light chains 0.0068 g/l and λ light chains 3.91 g/l; 24- h urine collection revealed 12 gr of proteins. A bone marrow examination revealed hypercellularity with a 70% infiltration of plasma cells and a blood smear with a 24% infiltration, which were CD38- positive, CD 138- positive and CD20- negative. The DNA content study showed hyperploidy. The renal biopsy revealed a massive infiltration of the tubulointerstitial compartment by plasma cells and heavy deposition of l- light chains [Figure 1] with no amyloid substance. We administered a VAD regimen on days 1- 4, 9- 12 and 17- 20 at 4- week intervals.
Figure 1: Kidney biopsy showing a diffuse infiltrate of atypical plasma cells mainly at the tubulointerstitial compartment (hematoxylin- eosin stain, original magnification × 400 , a) and λ light chains (b)

Click here to view


Despite aggressive chemotherapy regimen, response to treatment is still poor and successful therapeutic regimen has not been yet established. [1],[2] Our patient was treated following the VAD regimen having received five courses at 4- week intervals without hematological remission. The patient died from tumor progression 4 months post -diagnosis.

Up till now, immunophenotypic studies have shown that myeloma cells from PCL characteristically do not express CD56. [3] These data lead some authors to consider the absence of CD56 as a hallmark of PCL and that could discriminates it from MM. Here relies a striking difference of our report were the CD56- positivity is not in agreement with the vast majority of the medical literature (most works report CD56 - negativity). Very few cases have studied DNA cell content in their reports; the vast majority of cases have a DNA index of 1 or less. [4] Here is another difference since our patient displayed hyperdiploidy.

The hematological malignancies associated with nephrotic syndrome are mainly due to Hodgkin and non- Hodgkin's lymphoma and chronic lymphocytic leukemia. Renal disease occurs in up to 50% of patients with MM and sometimes, more than one is seen. Being multifactorial, renal dysfunction attributable to leukemic infiltration is rare and mainly described for chronic lymphocytic leukaemia. [5] To the best of our knowledge no case of such massive kidney infiltration by plasma cells has previously been reported. Renal failure has the potential to substantially jeopardize the chances of cancer patients receiving optimal treatment. The strategy has to consider both plasma cell clone and renal manifestations being necessarily a combined approach, which was not possible in our patient. [6]

 
 » References Top

1.Panizo C, Rifón J, Rodríguez- Wilhelmi P, Cuesta B, Rocha E. Long- term survival in primary plasma cell leukaemia after therapy with VAD, autologous blood stem cell transplantation and interferon- alpha. Acta Hamatol 1999;101:193-6.  Back to cited text no. 1
    
2.Wöhrer S, Ackermann J, Baldia C, Seidl S, Raderer M, Simonitsch I, et al. Effective treatment of primary plasma cell leukaemia with thalidomide and dexamethasone - a case report. Hematol J 2004;5:361-3.  Back to cited text no. 2
    
3.Pellat- Deceunynck C, Barillé S, Jego G, Puthier D, Robillard N, Pineau D, et al. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukaemia and of a special subset of multiple myeloma. Leukemia 1998;12:1977-82.  Back to cited text no. 3
    
4.Peijing Q, Yan X, Yafei W, Dehui Z, Zengjun L, Junyuan Q, et al.. A retrospective analysis of thirty- one cases of plasma cell leukaemia from a single center in China. Acta Haematol 2009;121:47- 51.  Back to cited text no. 4
    
5.Rifkin S. Acute renal failure secondary to chronic lymphocytic leukaemia: a case report. Medscape J Med 2008;10:67.  Back to cited text no. 5
    
6.Haubitz M, Peest D. Myeloma - new approaches to combined nephrological - haematological management. Nephrol Dial Transplant 2006;21:582-90.  Back to cited text no. 6
    


    Figures

  [Figure 1]



 

Top
Print this article  Email this article
 

    

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow